Alexander Vahrmeijer

Alexander Vahrmeijer is a Researcher in the Department of Surgery at Erasmus University Medical Center in Rotterdam, Netherlands. His ORCID profile (0000-0001-9370-0011) confirms his active research status with publications extending into 2025.

Dr. Vahrmeijer specializes in molecular imaging applications for surgical oncology, with particular expertise in fluorescence-guided cancer surgery techniques. His research fingerprint reveals substantial activity across multiple cancer domains: neoplasm research (100%), neoadjuvant therapy (61%), carcinoembryonic antigen studies (59%), rectum cancer (50%), colorectal carcinoma (46%), indocyanine green applications (45%), pancreas cancer (44%), and epithelial cell adhesion molecule research (24%). This profile demonstrates his focus on improving cancer surgery outcomes through advanced molecular targeting and imaging technologies.

Analysis of his recent publications shows a clear translational research trajectory from basic molecular targeting to clinical implementation. His work consistently addresses surgical precision challenges across gastrointestinal cancers, with particular emphasis on CEA-targeted imaging for rectal cancer, lymph node metastasis detection, and biomarker expression analysis in breast cancer. The progression from molecular probe development to clinical validation studies reflects his commitment to bringing innovative imaging techniques directly to the operating room.

Dr. Vahrmeijer maintains an active research program with 31 total publications, including 25 articles, 3 review articles, and additional scholarly works. His collaborative approach is evident through extensive co-authorship networks spanning multiple institutions and disciplines, including surgeons, oncologists, radiologists, and basic science researchers working together to advance cancer surgery techniques.